TILT-517

N/A

Report date: 2025/01/26 17:20:35

Base Information

Drug NameTILT-517
Drug Alias Nameoncolytic adenovirus therapy (TILT Biotherapeutics)TILT-517
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsCarcinoma, Renal CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTilt Biotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTilt Biotherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A